✦ LIBER ✦

Mo2054 Assessing Abdominal and Bowel Symptoms Using Adequate Relief Based Thresholds: Results From 2 Phase 3 Trials of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation

✍ Scribed by Camilleri, Michael; Lembo, Anthony; Lavins, Bernard J.; MacDougall, James E.; Shiff, Steven J.; Jia, Xinwei D.; Currie, Mark G.; Kurtz, Caroline B.; Johnston, Jeffrey M.

Book ID: 122239141
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 700 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)62706-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Effect of Linaclotide on Measures of

The Effect of Linaclotide on Measures of Abdominal and Bowel Symptoms in Patients With Chronic Constipation and Abdominal Pain: Pooled Results From Two Phase 3 Trials

✍ Anthony Lembo; Harvey Schneier; Bernard J. Lavins; Steven J. Shiff; James E. Mac 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 191 KB

475i Rifaximin Treatment for 2 Weeks Pro

475i Rifaximin Treatment for 2 Weeks Provides Acute and Sustained Relief Over 12 Weeks of IBS Symptoms in Non-Constipated Irritable Bowel Syndrome: Results From 2 North American Phase 3 Trials (Target 1 and Target 2)

✍ Mark Pimentel; Anthony Lembo; William D. Chey; Yehuda Ringel; Salam Zakko; Shadr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 132 KB